Actinogen MedicalASX:ACW -4.48% Quick Ratio is 4.19 as of Dec. 2025, which is 59% below its 10-year median of 10.34. The stock has 4 warning signs investors should review. Among 1,417 Biotechnology companies, Actinogen Medical ranks better than 54.27% on this metric.
Actinogen Medical has a quick ratio of 4.19. It generally indicates good short-term financial strength.
The historical rank and industry rank for Actinogen Medical's Quick Ratio or its related term are showing as below:
ASX:ACW'
s Quick Ratio Range Over the Past 10 Years
Min: 3.76 Med: 10.34 Max: 23.61
Current: 4.19
During the past 13 years, Actinogen Medical's highest Quick Ratio was 23.61. The lowest was 3.76. And the median was 10.34.
ASX:ACW's Quick Ratio is ranked better than 54.27% of 1417
companies
in the Biotechnology industry
Industry Median: 3.6
vs ASX:ACW: 4.19
Actinogen Medical (ASX:ACW) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Actinogen Medical Quick Ratio Related Terms
Actinogen Medical Quick Ratio Historical Data
* Premium members only.
The historical data trend for Actinogen Medical's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ACW vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Actinogen Medical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Actinogen Medical Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Actinogen Medical's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Actinogen Medical's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Actinogen Medical's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Actinogen Medical (ASX:ACW) has a Quick Ratio of 4.19 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Actinogen Medical and its competitors. This is 59% below median its historical median of 10.34. Over the past decade, Actinogen Medical's Quick Ratio has ranged from 3.76 to 23.61. According to the industry distribution chart, Actinogen Medical ranks #648 out of 1417 companies in the Biotechnology industry, placing it in the top 45.7%.
Is Actinogen Medical's Quick Ratio too high?
Actinogen Medical's current Quick Ratio of 4.19 is 59% below median its 10-year median of 10.34. Over the past 10 years, this metric has ranged from a low of 3.76 to a high of 23.61. The Biotechnology industry median Quick Ratio is 3.60. Actinogen Medical's value of 4.19 is 16.4% above this industry median. Based on the distribution chart, Actinogen Medical ranks #648 out of 1417 companies in the Biotechnology industry, which is above the industry midpoint.
How does Actinogen Medical's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Actinogen Medical ranks #648 out of 1417 companies for Quick Ratio. This puts Actinogen Medical in the upper half of its industry. The industry median Quick Ratio is 3.60. Actinogen Medical's value of 4.19 is 16.4% above this benchmark. Historically, Actinogen Medical's own Quick Ratio has ranged from 3.76 to 23.61 over the past decade. While the company's 10-year median is 10.34 vs. the industry median of 3.60, Actinogen Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,417 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Actinogen Medical's current Quick Ratio of 4.19 is 16.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Actinogen Medical and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Actinogen Medical's current Quick Ratio is 4.19, which is 59% below median its own 10-year median of 10.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Actinogen Medical stock overvalued right now?
Actinogen Medical (ASX:ACW) has a current Quick Ratio of 4.19. The current Quick Ratio is 4.19, which is 59% below median its 10-year median of 10.34 and 16.4% above the Biotechnology industry median of 3.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Actinogen Medical (ASX:ACW), the current Quick Ratio is 4.19 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Actinogen Medical Ltd is a biotechnology company. The company develops a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated cortisol in the brain. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ACW has been successfully added to your 